These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 26187754)

  • 41. Neuroprotection for amyotrophic lateral sclerosis: role of stem cells, growth factors, and gene therapy.
    Pandya RS; Mao LL; Zhou EW; Bowser R; Zhu Z; Zhu Y; Wang X
    Cent Nerv Syst Agents Med Chem; 2012 Mar; 12(1):15-27. PubMed ID: 22283698
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stem cell treatments for amyotrophic lateral sclerosis: a critical overview of early phase trials.
    Goutman SA; Savelieff MG; Sakowski SA; Feldman EL
    Expert Opin Investig Drugs; 2019 Jun; 28(6):525-543. PubMed ID: 31189354
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serial in vivo imaging of transplanted allogeneic neural stem cell survival in a mouse model of amyotrophic lateral sclerosis.
    Srivastava AK; Gross SK; Almad AA; Bulte CA; Maragakis NJ; Bulte JWM
    Exp Neurol; 2017 Mar; 289():96-102. PubMed ID: 28038988
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model.
    Nizzardo M; Simone C; Rizzo F; Ruggieri M; Salani S; Riboldi G; Faravelli I; Zanetta C; Bresolin N; Comi GP; Corti S
    Hum Mol Genet; 2014 Jan; 23(2):342-54. PubMed ID: 24006477
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Advances, Challenges, and Perspectives in Translational Stem Cell Therapy for Amyotrophic Lateral Sclerosis.
    Abati E; Bresolin N; Comi G; Corti S
    Mol Neurobiol; 2019 Oct; 56(10):6703-6715. PubMed ID: 30911936
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model.
    Marconi S; Bonaconsa M; Scambi I; Squintani GM; Rui W; Turano E; Ungaro D; D'Agostino S; Barbieri F; Angiari S; Farinazzo A; Constantin G; Del Carro U; Bonetti B; Mariotti R
    Neuroscience; 2013 Sep; 248():333-43. PubMed ID: 23727509
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neural induction with neurogenin 1 enhances the therapeutic potential of mesenchymal stem cells in an amyotrophic lateral sclerosis mouse model.
    Chan-Il C; Young-Don L; Heejaung K; Kim SH; Suh-Kim H; Kim SS
    Cell Transplant; 2013; 22(5):855-70. PubMed ID: 22472631
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
    Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
    Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of Plant-Derived Compounds on Amyotrophic Lateral Sclerosis.
    de Oliveira LMG; Carreira RB; de Oliveira JVR; do Nascimento RP; Dos Santos Souza C; Trias E; da Silva VDA; Costa SL
    Neurotox Res; 2023 Jun; 41(3):288-309. PubMed ID: 36800114
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis.
    Hooten KG; Beers DR; Zhao W; Appel SH
    Neurotherapeutics; 2015 Apr; 12(2):364-75. PubMed ID: 25567201
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Meeting report of the International Consortium of Stem Cell Networks' Workshop Towards Clinical Trials Using Stem Cells for Amyotrophic Lateral Sclerosis/Motor Neuron Disease.
    Chaddah MR; Dickie BG; Lyall D; Marshall CJ; Sykes JB; Bruijn LI
    Amyotroph Lateral Scler; 2011 Sep; 12(5):315-7. PubMed ID: 21812627
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SRSF1-dependent inhibition of C9ORF72-repeat RNA nuclear export: genome-wide mechanisms for neuroprotection in amyotrophic lateral sclerosis.
    Castelli LM; Cutillo L; Souza CDS; Sanchez-Martinez A; Granata I; Lin YH; Myszczynska MA; Heath PR; Livesey MR; Ning K; Azzouz M; Shaw PJ; Guarracino MR; Whitworth AJ; Ferraiuolo L; Milo M; Hautbergue GM
    Mol Neurodegener; 2021 Aug; 16(1):53. PubMed ID: 34376242
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: phase 1 trial outcomes.
    Feldman EL; Boulis NM; Hur J; Johe K; Rutkove SB; Federici T; Polak M; Bordeau J; Sakowski SA; Glass JD
    Ann Neurol; 2014 Mar; 75(3):363-73. PubMed ID: 24510776
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stem cell-derived motor neurons: applications and challenges in amyotrophic lateral sclerosis.
    Thonhoff JR; Ojeda L; Wu P
    Curr Stem Cell Res Ther; 2009 Sep; 4(3):178-99. PubMed ID: 19492980
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induced pluripotent stem cells from ALS patients for disease modeling.
    Richard JP; Maragakis NJ
    Brain Res; 2015 May; 1607():15-25. PubMed ID: 25223906
    [TBL] [Abstract][Full Text] [Related]  

  • 56. RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue.
    Vallarola A; Sironi F; Tortarolo M; Gatto N; De Gioia R; Pasetto L; De Paola M; Mariani A; Ghosh S; Watson R; Kalmes A; Bonetto V; Bendotti C
    J Neuroinflammation; 2018 Mar; 15(1):65. PubMed ID: 29495962
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transplantation of Neural Progenitor Cells Expressing Glial Cell Line-Derived Neurotrophic Factor into the Motor Cortex as a Strategy to Treat Amyotrophic Lateral Sclerosis.
    Thomsen GM; Avalos P; Ma AA; Alkaslasi M; Cho N; Wyss L; Vit JP; Godoy M; Suezaki P; Shelest O; Bankiewicz KS; Svendsen CN
    Stem Cells; 2018 Jul; 36(7):1122-1131. PubMed ID: 29656478
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stem cells therapy for ALS.
    Mazzini L; Vescovi A; Cantello R; Gelati M; Vercelli A
    Expert Opin Biol Ther; 2016; 16(2):187-99. PubMed ID: 26558293
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice.
    Hwang DH; Lee HJ; Park IH; Seok JI; Kim BG; Joo IS; Kim SU
    Gene Ther; 2009 Oct; 16(10):1234-44. PubMed ID: 19626053
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of amyotrophic lateral sclerosis.
    Corti S; Nizzardo M; Nardini M; Donadoni C; Salani S; Simone C; Falcone M; Riboldi G; Govoni A; Bresolin N; Comi GP
    Hum Mol Genet; 2010 Oct; 19(19):3782-96. PubMed ID: 20650960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.